Dr. Robert Gundel

Robert Gundel holds a PhD in Physiology and an MBA and was the CEO and a Board Member of Amorfix Life Sciences from 2009 to 2015. Dr. Gundel has held several leadership roles in a number of pharmaceutical companies including CSO of Arius Research, Vice President of Preclinical Development and Corporate Development at XOMA, Vice President of Pharmacology at Chiron Corporation and Director of Pharmacology at Bayer Corporation.  Dr. Gundel founded RH Gundel Pharmaceutical Consulting in 2015; a firm that provides professional services for several business needs including Preclinical and Clinical Development, Project Management, Investor and Public Relations, Business Development, Medical Research, Market Research and Medical Writing.  Dr. Gundel  has published more than 70 peer-reviewed articles in top tier medical journals, authored12 medical book chapters and more than 90 scientific abstracts presented at national and international scientific conferences